MENU
NKTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Nkarta (NKTX) Earnings Date & Reports
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies... Show more
A.I. Advisor
published Earnings
NKTX is expected to report earnings to fall 1.62% to -36 cents per share on August 06
Q2'26
Est.
$-0.36
Q1'26
Missed
by $0.02
Q4'25
Missed
by $0.06
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.04
The last earnings report on May 12 showed earnings per share of -37 cents, missing the estimate of -34 cents. With 177.64K shares outstanding, the current market capitalization sits at 171.71M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer
Industry Biotechnology
Profile
Details
Industry
N/A
Address
1150 Veterans Boulevard
Phone
+1 905 407-1049
Employees
108
Web
https://www.nkartatx.com